WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2012049646) PROCESS FOR THE PREPARATION OF AN INTERMEDIATE OF CILAZAPRIL
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2012/049646    International Application No.:    PCT/IB2011/054520
Publication Date: 19.04.2012 International Filing Date: 12.10.2011
IPC:
C07D 403/06 (2006.01), C07D 487/04 (2006.01)
Applicants: RANBAXY LABORATORIES LIMITED [IN/IN]; Head Office: 12th Floor, Devika Tower, 06 Nehru Place New Delhi, Delhi 110019 (IN) (For All Designated States Except US).
KUMAR, Harish [IN/IN]; (IN) (For US Only).
PAREKH, Amar [IN/IN]; (IN) (For All Designated States Except US).
ARORA, Sanjeev Kumar [IN/IN]; (IN) (For US Only).
SINGH, Kaptan [IN/IN]; (IN) (For All Designated States Except US).
PRASAD, Mohan [IN/IN]; (IN) (For All Designated States Except US).
ARORA, Sudershan [US/IN]; (IN) (For All Designated States Except US)
Inventors: KUMAR, Harish; (IN).
ARORA, Sanjeev Kumar; (IN).
SINGH, Kaptan; (IN).
PRASAD, Mohan; (IN).
ARORA, Sudershan; (IN)
Common
Representative:
RANBAXY LABORATORIES LIMITED; c/o B. Vijayaraghavan Intellectual Property Dept., 600 College Road East, Suite 2100 Princeton, New Jersey 08540 (US)
Priority Data:
2429/DEL/2010 12.10.2010 IN
Title (EN) PROCESS FOR THE PREPARATION OF AN INTERMEDIATE OF CILAZAPRIL
(FR) PROCÉDÉ DE PRÉPARATION D'UN INTERMÉDIAIRE DE CILAZAPRIL
Abstract: front page image
(EN)The present invention relates to a process for the preparation of optically pure (S,S)-6-t-butoxycarbonyl-hexahydro-1-pyridazinylcarbonyl-1,3-dioxo-2-isoindolebutyric acid, an intermediate for the preparation of cilazapril.
(FR)La présente invention concerne un procédé de préparation de (S,S)-6-t-butoxycarbonyl-hexahydro-1-pyridazinylcarbonyl-1,3-dioxo-2-acide isoindolebutyrique optiquement pur, intermédiaire dans la préparation du cilazapril.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)